| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | Not provided |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
QuantiHealth ® After 11 years of dedicated precipitation, we currently have the largest and most diverse human symbiotic bacterial library in China (commercially available), with a wide range of functional categories and clinical level effects. At the same time, we have also mastered 405 intestinal disease models, providing scientific basis for in-depth exploration of prevention, diagnosis, and treatment of intestinal related diseases. QuantiHealth ® Mastering the preparation technology of drug grade live bacteria aims to change the current situation of limited strain sources and single efficacy of probiotic products in China, and provide high-quality and affordable domestic alternative options for the rapid launch of probiotic food/live biopharmaceutical products by domestic food and pharmaceutical enterprises.
沪公网安备31010402001403号
